The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CLVT | -34.1% | -87.27% | -33.78% | -74% |
| S&P | +12.33% | +84.73% | +13.06% | +137% |
Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Life Sciences and Healthcare (LS&H), and Intellectual Property (IP). The A&G segment consists of products and services to organizations that plan, fund, implement, and utilize education and research at a global, national, institutional, and individual level. The LS&H segment comprises of products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations. The IP segment refers to patent intelligence, brand IP Intelligence, and IP Lifecycle Management product groups, which enables customers to establish, protect, and manage their intellectual property and form critical business decision while also mitigating risk and improving efficiencies. The company was founded in 1864 and is headquartered in London, the United Kingdom.
The Motley Fool analyzed 16 hedge funds run by billionaires to determine what the wealthiest investors are buying.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $623.10M | 0.1% |
| Gross Profit | $213.10M | -9.3% |
| Gross Margin | 34.20% | -3.6% |
| Market Cap | $2.57B | -49.9% |
| Market Cap / Employee | $0.21M | 0.0% |
| Employees | 12K | 0.0% |
| Net Income | -$28.30M | 56.9% |
| EBITDA | $239.00M | -1.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $318.70M | -18.0% |
| Accounts Receivable | $810.70M | 5.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $4.46B | -4.9% |
| Short Term Debt | $18.70M | -58.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -3.41% | 6.7% |
| Return On Invested Capital | -10.53% | 0.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $115.50M | -8.6% |
| Operating Free Cash Flow | $181.10M | -10.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.65 | 0.53 | 0.58 | 0.52 | -43.80% |
| Price to Sales | 1.40 | 1.07 | 1.17 | 1.02 | -48.31% |
| Price to Tangible Book Value | -0.73 | -0.56 | -0.60 | -0.53 | -49.44% |
| Price to Free Cash Flow TTM | 11.91 | 8.03 | 8.99 | 8.12 | -41.27% |
| Enterprise Value to EBITDA | 30.91 | 33.38 | 30.22 | 28.12 | -27.87% |
| Free Cash Flow Yield | 8.4% | 12.4% | 11.1% | 12.3% | 70.28% |
| Return on Equity | -11.4% | -12.2% | -8.2% | -7.6% | -64.03% |
| Total Debt | $4.59B | $4.60B | $4.59B | $4.48B | -5.40% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
